New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 7, 2013
06:55 EDTTPI, TPI, TPI, ANX, ANX, ANX, AGEN, AGEN, AGEN, CTSO, CTSO, CTSO, ATOS, ATOS, ATOS, SYN, SYN, SYN, OXBT, OXBT, OXBT, CLRX, CLRX, CLRX, BONE, BONE, BONEOneMedPlace to host a forum
6th Annual OneMedForum 2013 is being held in San Francisco on January 7-9.
News For TPI;ANX;AGEN;CTSO;ATOS;SYN;OXBT;CLRX;BONE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 29, 2015
09:18 EDTSYNOn The Fly: Pre-market Movers
Subscribe for More Information
07:36 EDTAGENAgenus coverage assumed with a Buy at H.C. Wainwright
Subscribe for More Information
07:00 EDTSYNSynthetic Biologics initiates SYN-010 Phase 2 clinical trial
Synthetic Biologics reported the initiation of a Phase 2 clinical trial of its proprietary SYN-010 for the treatment of irritable bowel syndrome with constipation, or IBS-C. This is a placebo-controlled study to evaluate the ability of two dose strengths of SYN-010 to reduce the production of methane in breath methane-positive patients with IBS-C. Breath methane is strongly associated with constipation in IBS-C and higher methane levels are proportional to constipation severity. This Phase 2, randomized, double-blind, parallel-group, placebo-controlled, multi-dose study is expected to be conducted at multiple centers in the United States. The primary objective of this study is to evaluate the change from baseline in breath methane, as determined by a lactulose breath test, in methane-positive patients with IBS-C after seven days of treatment with one of two formulations of SYN-010 compared with placebo. Approximately 60 patients will be enrolled and randomly assigned in a 1:1:1 ratio to one of three groups, including two different SYN-010 dose groups and a placebo group. Patients are scheduled to receive single oral doses of SYN-010 each day for 28 days.
06:47 EDTATOSAtossa Genetics files to sell 5.4M shares for holder Aspire Capital
Subscribe for More Information
June 23, 2015
13:00 EDTAGENTheStreet's Feuerstein pans bullish Agenus initiation
Subscribe for More Information
07:36 EDTAGENJMP Securities to hold a conference
Subscribe for More Information
June 19, 2015
15:40 EDTATOSAtossa participates in a meeting with Philadelphia Securities Association
Subscribe for More Information
June 17, 2015
07:01 EDTSYN, AGENAgenus names C. Evan Ballantyne as CFO, effective immediately
Subscribe for More Information
June 16, 2015
06:55 EDTCTSOCytoSorbents management to meet with Benchmark Co
Meetings to be held in Boston on June 17 and in Philadelphia on June 18 hosted by Benchmark Co.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use